Clinical trial
Gabapentin for Carpal Tunnel Syndrome
NCT00137735 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00137735 |
|---|---|
| Title | Gabapentin for Carpal Tunnel Syndrome |
| Official title | Gabapentin for Carpal Tunnel Syndrome: A Randomised Controlled Trial |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carpal Tunnel Syndrome |
| Intervention type | Drug, Other |
| Interventions | Gabapentin, placebo |
| Enrollment | 150 |
| Start date | Oct 1, 2003 |
| Completion | Dec 1, 2006 |
| First posted | Aug 30, 2005 |
| Last update posted | Oct 31, 2007 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: